Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

This study is testing a new oral drug called AU409 in people with advanced liver cancer (hepatocellular carcinoma) who have already tried and failed standard treatments, including immunotherapy and targeted drugs. **You may be eligible if...** - You are between 18 and 75 years old with confirmed advanced or metastatic liver cancer - You have already tried standard treatments (including immunotherapy and/or targeted therapies or chemotherapy) and your cancer has progressed - At least 4 weeks have passed since your last treatment - You have at least one measurable tumor lesion **You may NOT be eligible if...** - You have not yet tried available standard treatments - Your organ function does not meet minimum requirements - You have uncontrolled infections, uncontrolled bleeding, or significant heart disease Talk to your doctor to see if this trial is right for you.